Evaluation of Anti-Hyperlipidemic Activity of Nimbin in Wistar Rat

Abstract

The present research work was to explore the anti-hyperlipidemic potential of Nimbin (2 miligram-kilogram /or 4 miligram-kilogram/, p.o).  Hyperlipidemia is a largly growing disease. Hyperlipidemia is a disorder that is rapidly increasing in prevalence.Hyperlipidemia affects almost 30 million people in the United States, and current trends suggest that one out of every three adults will have diabetes by 2050 if current trends continue.Dexamethasone and Triton induced hyperlipidemia model was used to evaluate the anti-hyperlipidemic activity. In case of hyperlipidemia (4 miligram-kilogram/, p.o) is more effective comparison to 2 miligram-kilogram/ p.o. Research outcome indicates that Nimbin (2 miligram-kilogram/ p.o or 4 miligram-kilogram/ p.o) is having significant anti-hyperlipidemic potential.